Cancer Epidemiology (CE)
Journal Descriptions
Cancer Epidemiology is a peer‑reviewed scientific journal dedicated to advancing knowledge about the epidemiology of cancer — the study of cancer patterns, causes, risk factors, prevention strategies, early detection, prognostic outcomes, and methodological issues in population‑based research. It provides a global platform for researchers, clinicians, and public health professionals to publish high‑quality original research articles, systematic and critical reviews, meta‑analyses, commentaries, and letters that deepen understanding of how cancer arises and progresses across diverse populations and environments. The journal emphasizes work that contributes new evidence on risk factors, lifestyle and environmental influences, screening and early diagnosis, survivorship, and interventions that can lead to improved cancer control and reduced burden worldwide. By integrating epidemiology with public health insights, Cancer Epidemiology supports evidence‑based policies, guides clinical practice, and identifies emerging trends in cancer incidence and outcomes. Indexed in major databases including MEDLINE/PubMed and the Science Citation Index Expanded, the journal has international reach and influence across oncology, population health, and preventive medicine. Its multidisciplinary scope attracts contributions from epidemiologists, biostatisticians, oncologists, and public health experts committed to reducing cancer risk and improving patient and population outcomes.
Cancer Epidemiology (CE) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Epidemiology, Cancer Research, Oncology, causes, risk factors, prevention, detection, screening, prognosis, survivorship, descriptive patterns, and research methodology related to cancer incidence , Online or Print , Bi-Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1877-7821, E-ISSN: 1877-783X, Established: 1976, Impact Factor: 2.3
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE